PART I We are a pioneering gene editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The promise of genomic medicines is supported by the advancing knowledge of the human genome and by harnessing the progress in technologies for cell therapy, gene therapy, and, most recently, gene editing. We believe this progress sets the stage for us to create medicines with the potential to have a durable benefit for patients. Our cor...
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001650664-26-000017 | EDGAR | 112K words |
| 2025-03-05 | 2024-12-31 | 0001650664-25-000022 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001650664-24-000008 | EDGAR | — |
| 2023-02-22 | 2022-12-31 | 0001558370-23-001764 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001558370-22-001950 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001558370-21-001915 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001558370-20-001476 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001558370-19-001364 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001558370-18-001721 | EDGAR | — |
| 2017-03-03 | 2016-12-31 | 0001558370-17-001340 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001650664-26-000083 | EDGAR | — |
| 2025-11-10 | 2025-09-30 | 0001650664-25-000156 | EDGAR | 21K words |
| 2025-08-12 | 2025-06-30 | 0001650664-25-000125 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001650664-25-000073 | EDGAR | — |
| 2024-11-04 | 2024-09-30 | 0001650664-24-000121 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001650664-24-000097 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001650664-24-000037 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001650664-23-000017 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001558370-23-012936 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001558370-23-008308 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0001558370-22-016012 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001558370-22-011904 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001650664-26-000082 | EDGAR | — |
| 2026-03-27 | 0001650664-26-000027 | EDGAR | 1K words |
| 2026-03-09 | 0001650664-26-000013 | EDGAR | — |
| 2025-11-10 | 0001650664-25-000153 | EDGAR | — |
| 2025-10-09 | 0001650664-25-000148 | EDGAR | — |
| 2025-09-02 | 0001650664-25-000134 | EDGAR | — |
| 2025-08-12 | 0001650664-25-000123 | EDGAR | — |
| 2025-06-12 | 0001650664-25-000106 | EDGAR | — |
| 2025-06-02 | 0001650664-25-000086 | EDGAR | — |
| 2025-05-14 | 0001650664-25-000081 | EDGAR | — |
193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001650664 |
| Ticker | EDIT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.editasmedicine.com |
| Listed | 2016-02-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/EDIT (~200 tokens, structured JSON with cryptographic provenance)